Dr. Jérémy Tricard, MD

Claim this profile

Institut Universitaire de Cardiologie et de Pneumologie de Québec

Studies Lung Cancer
Studies Circulating Tumor Cells
1 reported clinical trial
2 drugs studied

Affiliated Hospitals

Image of trial facility.
Institut Universitaire De Cardiologie Et De Pneumologie De Québec

More about Jérémy Tricard, MD

Clinical Trial Related6 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Jérémy Tricard, MD has experience with
  • Arteries Interruption Before Vein Interruption
  • Vein Interruption Before Any Other Surgical Manipulation
Breakdown of trials Jérémy Tricard, MD has run

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jérémy Tricard, MD specialize in?
Jérémy Tricard, MD focuses on Lung Cancer and Circulating Tumor Cells. In particular, much of their work with Lung Cancer has involved treating patients, or patients who are undergoing treatment.
Is Jérémy Tricard, MD currently recruiting for clinical trials?
No, Jérémy Tricard, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Jérémy Tricard, MD has studied deeply?
Yes, Jérémy Tricard, MD has studied treatments such as Arteries interruption before vein interruption, Vein interruption before any other surgical manipulation.
What is the best way to schedule an appointment with Jérémy Tricard, MD?
Apply for one of the trials that Jérémy Tricard, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.